Vibe Bioscience Ltd. (CSE: VIBE) (the “Company” or “Vibe”), a
vertically integrated cannabis retailer and cultivator, is pleased
to announce the completion of Phase 1 of its cultivation expansion,
and its financial and operating results for the three and nine
months ended September 30, 2019. All financial information is
provided in U.S. dollars (“USD”) unless otherwise indicated. The
Financial Statements and Management’s Discussion and Analysis
(“MD&A”) for the three and nine months ended September 30, 2019
are available on the Company’s SEDAR profile at www.sedar.com and
on Vibe’s website at www.vibebycalifornia.com.
Completion of Phase 1 Cultivation
Expansion at Sacramento, California Campus
Vibe is pleased to announce the completion of
the first phase of its build-out of the Company’s 3,000 sq. ft.
nursery in Sacramento, California. The purpose-built nursery is
intended to support Vibe’s cultivation expansion plans at its
Sacramento Campus, which hosts both cultivation and retail
operations. The completion of the nursery is expected to provide
the following benefits:
- Larger scale operations that will extend vegetation growth
phases, increasing Vibe’s potential harvest schedule from 4 to 5
cycles per year;
- Increase production yield by approximately 20-25%, while
decreasing operational costs per gram produced;
- Expand production capabilities allowing Vibe to better supply
its clientele with high-quality Hype Cannabis branded
products;
- Facilitate the wholesale production of high demand clones
available for sale to the retail market; and
- Provide research and development space for the Company’s
cultivation team, giving them the ability to produce new strains
and increase Vibe’s in-store product offering. (b)
"The completion of Phase-1 of our upgrades to
the Sacramento nursery is continuing evidence of our ability to
execute on our plan to advance our business through organic growth
and disciplined operations," said Vibe’s CEO Mark Waldron. "We are
excited by the opportunity this expansion gives us in ensuring the
quality and variety of exceptional products we offer customers in
our Vibe by California stores."
Q3 2019 Financial
Highlights:
Vibe Bioscience Corporation (the reverse
takeover acquiror of Altitude Resources Inc.) was incorporated on
June 11, 2018. Following the takeover, the only material
transactions in the three months ended September 30, 2018 consisted
of administrative expenses related to the acquisition of the Vibe’s
core cannabis business and those related to the Company’s listing
on the Canadian Securities Exchange. Vibe’s cannabis operations
commenced on February 18, 2019 with the acquisition of certain
dispensary and cultivation assets in California (the “U.S.
Operations”).
Consolidated (U.S. Operations and
Canadian Head Office) Highlights
USD |
Q3 2019 |
Q2 2019 |
Change |
% Change |
|
Total revenue(a) |
$ |
4,176,747 |
$ |
3,096,836 |
$ |
1,079,911 |
35 |
% |
Gross margin |
$ |
1,560,073 |
$ |
1,296,113 |
$ |
263,960 |
20 |
% |
Adjusted EBITDA(a) |
$ |
278,979 |
$ |
113,322 |
$ |
165,657 |
146 |
% |
Gross Margin
%(a) |
37.4 |
41.9 |
- |
- |
|
Adjusted
EBITDA %(a) |
6.7 |
3.7 |
- |
|
|
|
|
(a) This is a non-IFRS measure. Readers are
cautioned that the amounts presented do not have standardized
meanings prescribed by IFRS – see discussion of non-IFRS Measures
in the MD&A for reconciliation to measures reported in the
Company’s financial statements.
U.S. Retail Highlights
USD |
Q3 2019 |
Q2 2019 |
Change |
% Change |
|
Revenue(a) |
$ |
3,959,387 |
$ |
2,898,975 |
$ |
1,060,412 |
37 |
% |
Gross margin(a) |
$ |
1,594,798 |
$ |
1,428,025 |
$ |
166,773 |
12 |
% |
Gross Margin %(a) |
40.3 |
49.3 |
- |
- |
|
|
(a) This is a non-IFRS measure. Readers are
cautioned that the amounts presented do not have standardized
meanings prescribed by IFRS – see discussion of non-IFRS Measures
in the MD&A for reconciliation to measures reported in the
Company’s financial statements.
Q3 2019 Corporate Development Highlights:
- U.S. dispensary and
cultivation operations continued their positive results in the
third quarter of 2019: The U.S. Operations generated
revenue and adjusted EBITDA(a) of $4,176,747 and $713,717 in the
three months ended September 30, 2019, a 35% and 6% increase
respectively, compared to revenue and adjusted EBITDA(a) of
$3,096,836 and $673,505, respectively, in the second quarter of
2019. In the nine months ended September 30, 2019, U.S. operations
generated revenue and adjusted EBITDA(a) of $8,587,309 and
$1,718,092, respectively. While sales volumes have increased, gross
margins have decreased due to competitive market pressures.
- Delivery service
commenced: In June 2019 the Company, through its
wholly-owned subsidiary Alpine Alternative Naturopathic Inc.
(“Alpine Alternative”), was granted a delivery license for the City
of Sacramento, which allows for door-to-door delivery of cannabis
products throughout California’s Central Valley. The Company
launched its delivery service on June 7, 2019 and expects to
realize the benefits of the delivery license throughout the
remainder of 2019 and into 2020 as customers become familiar with
the service offering.(b)
- New extracts product
development completed: In the second quarter of 2019, the
Company completed the development of its new “Hype Extracts” brand
extracts products. In October 2019, the Company entered into a
strategic extraction agreement with a Sacramento-area manufacturer
to expand its Hype Extracts line. Under the terms of the agreement,
Vibe and the manufacturer will procure bulk quantities of
fresh-frozen and/or premium dried cannabis for an initial six-month
term that commenced on October 23, 2019. Under the terms of the
agreement, the manufacturer will provide extraction, formulation
and production services for the development of distillate, live
resin, wax and other cannabis oil derivatives to be sold under the
Hype Extracts brand on a fee-for-service basis.(b)
Operations Review:
The third quarter of 2019 was positive for the
Company, building from the positive results realized in the first
half of the year. The U.S. Operations contributed revenue and gross
margin(a) of $4,176,747 and $1,560,073, respectively, in the third
quarter and contributed adjusted EBITDA(a) of $713,717. As of
September 30, 2019, the U.S. Operations have generated positive
results for the Company realizing $1,718,092 of adjusted EBITDA(a)
on revenue of $8,587,309 since their acquisition in February
2019.
The U.S. Operations benefited from positive
seasonal effects in both the second and third quarters of 2019.
Alpine Alternative also launched its door-to-door delivery service
in June 2019 and improvements to the store layout continue in
connection with the first phase of the upgrades and enhancements at
the Vibe Cultivation LLC and Alpine Alternative facilities.
The Company completed the development of its new
“Hype Extracts” brand extracts products in the second quarter of
2019, which the Company started selling through the Company’s
retail dispensaries in August 2019. In addition, Alpine Alternative
received a delivery license from the City of Sacramento in June
2019 and subsequently commenced door-to-door delivery service, the
benefit of which is expected to be realized through the remainder
of 2019 and into 2020.(b) Vibe believes that by providing multiple
and varied ways of product payment and delivery, the Company will
attract a broader and more diverse customer demographic and further
increase customer loyalty.(b)
The Company is prudently monitoring its general
and administrative expenditures and aiming to eliminate all
non-essential costs. The Company incurred a one-time $100,000
restructuring charge with respect to its Canadian head office,
which the Company expects will result in future savings of
approximately $30,000 per month.(b)
As a result of the restructuring of the Canadian
head office, and the Company’s decision not to allocate capital to
the development licenses in Canada and instead to focus on the U.S.
Operations, the Company recognized a one-time $1,881,065 non-cash
charge related to certain Canadian intangible assets.
About Vibe
Vibe is a vertically integrated cannabis company
whose mission is to become an industry-leading multi-state
operator. The Company delivers exceptional retail experiences with
its “Vibe by California” brand and ethos, premier cultivation
product, and high-efficiency delivery and distribution. The
Company’s management team brings expertise in retail, cannabis
cultivation, and mergers and acquisitions to support its U.S.
expansion through accretive acquisitions and organic growth.
Vibe is focused on completing strategic
acquisitions during the remainder of 2019 and has an additional
dispensary in Redding, California under the definitive agreement.
The Redding dispensary does not currently have any operations, and
therefore, will not be immediately profitable or cash flow positive
to the Company. However, management believes the proposed
acquisition of the Redding dispensary is a cost-effective means of
acquiring a retail license, and therefore, increasing market share
in the northern California retail cannabis market.(b)
The Redding dispensary is currently undergoing
improvements that will result in it being the first location to be
entirely branded under the “Vibe by California” store name. The
Redding location is expected to become fully operational in early
December 2019(b). Closing of the Redding acquisition is expected to
occur in the four quarter of 2019, pending the satisfaction of
customary closing conditions associated with the acquisition
(including receipt of all necessary third-party consents and
approvals).
Management remains focused on generating revenue
growth organically through investment in product development,
existing cultivation and retail infrastructure. The Company
believes that by investing in product development and cultivation,
manufacturing and distribution operations it will be able to
increase sales from its existing retail channel in addition to
gaining market share in the wholesale supply of
cannabis.(b)
For more information, please visit our website
at www.vibebycalifornia.com and sign-up for our mailing list.
Further details about Vibe are included in Vibe's Listing Statement
(CSE Form 2) available on SEDAR at www.sedar.com and at
www.vibebycalifornia.com
Company Contact:
Mark Waldron, CEO Phone: +1 833-420-VIBE Email:
info@vibebycalifornia.com
_______________________________________________________
(a) Readers are cautioned that these
measures are non-IFRS measures and do not have standardized
meanings prescribed by IFRS. See discussion of Non-IFRS Measures in
the Q3 2019 MD&A for reconciliation to IFRS amounts reported in
Vibe’s financial statements.(b) Readers are cautioned that these
statements represent forward looking information that is based on
various assumptions and subject to certain risk factors – see
discussion of Forward Looking Information, below, and Cautionary
Note Regarding Forward Looking Information in the Q3 2019
MD&A.
Investor Relations Contact:Glen Nelson Phone:
+1 833-420-VIBE x 107 Email: ir@vibebycalifornia.com
Forward-Looking Information
Certain statements contained in this press
release constitute forward-looking information. These statements
relate to future events or future performance. The use of any of
the words “anticipate”, “could”, “intend”, “expect”, “believe”,
“will”, “projected”, “estimated” and similar expressions and
statements relating to matters that are not historical facts are
intended to identify forward-looking information and are based on
the parties’ current belief or assumptions as to the outcome and
timing of such future events. Actual future results may differ
materially.
The forward-looking information contained in
this release is made as of the date hereof and the parties are not
obligated to update or revise any forward-looking information,
whether as a result of new information, future events or otherwise,
except as required by applicable securities laws. Because of the
risks, uncertainties and assumptions contained herein, investors
should not place undue reliance on forward looking information. The
foregoing statements expressly qualify any forward-looking
information contained herein. Risk factors related to the Company
are described in the Company’s Listing Statement dated March 25,
2019 and most recently filed management’s discussion and analysis,
copies of which are available under the Company’s profile on
SEDAR.
This press release does not constitute an offer
to sell or a solicitation of an offer to buy any of the securities
in the United States. The securities have not been and will not be
registered under the United States Securities Act of 1933, as
amended (the “U.S. Securities Act”) or any State securities laws
and may not be offered or sold within the United States or to U.S.
Persons unless registered under the U.S. Securities Act and
applicable State securities laws or an exemption from such
registration is available. Not for distribution to U.S. Newswire
Services or for dissemination in the United States. Any failure to
comply with this restriction may constitute a violation of U.S.
securities laws.
Unlike in Canada which has Federal legislation
uniformly governing the cultivation, distribution, sale and
possession of cannabis under the Cannabis Act (Federal), readers
are cautioned that in the U.S., cannabis is largely regulated at
the State level. To the knowledge of Vibe Bioscience Ltd., there
are to date a total of 33 states, plus the District of Columbia,
that have legalized cannabis in some form. Notwithstanding the
permissive regulatory environment of medical cannabis at the State
level, cannabis continues to be categorized as a controlled
substance under the Controlled Substances Act in the U.S. and as
such, cannabis-related practices or activities, including without
limitation, the manufacture, importation, possession, use or
distribution of cannabis are illegal under U.S. Federal law. Strict
compliance with State laws with respect to cannabis will neither
absolve Vibe Bioscience Ltd. of liability under the U.S. Federal
law, nor will it provide a defense to any Federal proceeding, which
may be brought against Vibe Bioscience Ltd. Any such proceedings
brought against Vibe Bioscience Ltd. may adversely affect its
operations and financial performance.
Vibe Growth (CSE:VIBE)
過去 株価チャート
から 11 2024 まで 12 2024
Vibe Growth (CSE:VIBE)
過去 株価チャート
から 12 2023 まで 12 2024